These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31041407)

  • 1. High prevalence of fluoroquinolone-resistant Escherichia coli strains isolated from urine clinical samples.
    Dehbanipour R; Khanahmad H; Sedighi M; Bialvaei AZ; Faghri J
    J Prev Med Hyg; 2019 Mar; 60(1):E25-E30. PubMed ID: 31041407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in Klebsiella pneumoniae clinical isolates.
    Rezaei S; Tajbakhsh S; Naeimi B; Yousefi F
    BMC Microbiol; 2024 Jul; 24(1):265. PubMed ID: 39026143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran.
    Mirzaii M; Jamshidi S; Zamanzadeh M; Marashifard M; Malek Hosseini SAA; Haeili M; Jahanbin F; Mansouri F; Darban-Sarokhalil D; Khoramrooz SS
    J Glob Antimicrob Resist; 2018 Jun; 13():197-200. PubMed ID: 29747008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S; Tandon V
    Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of DNA gyrase and topoisomerase IV mutations and plasmid-mediated quinolone resistance genes among Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in Azerbaijan, Iran.
    Azargun R; Soroush Barhaghi MH; Samadi Kafil H; Ahangar Oskouee M; Sadeghi V; Memar MY; Ghotaslou R
    J Glob Antimicrob Resist; 2019 Jun; 17():39-43. PubMed ID: 30445211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid Detection of Genomic Mutations in gyrA and parC Genes of Escherichia coli by Multiplex Allele Specific Polymerase Chain Reaction.
    Onseedaeng S; Ratthawongjirakul P
    J Clin Lab Anal; 2016 Nov; 30(6):947-955. PubMed ID: 27075845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone resistance and molecular characterization of gyrA and parC quinolone resistance-determining regions in Escherichia coli isolated from poultry.
    Vanni M; Meucci V; Tognetti R; Cagnardi P; Montesissa C; Piccirillo A; Rossi AM; Di Bello D; Intorre L
    Poult Sci; 2014 Apr; 93(4):856-63. PubMed ID: 24706962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
    Ling JM; Chan EW; Lam AW; Cheng AF
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya.
    Kivata MW; Mbuchi M; Eyase FL; Bulimo WD; Kyanya CK; Oundo V; Muriithi SW; Andagalu B; Mbinda WM; Soge OO; McClelland RS; Sang W; Mancuso JD
    BMC Microbiol; 2019 Apr; 19(1):76. PubMed ID: 30961546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.
    Zeng L; Zhang J; Li C; Fu Y; Zhao Y; Wang Y; Zhao J; Guo Y; Zhang X
    Infect Genet Evol; 2020 Aug; 82():104319. PubMed ID: 32278145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and mechanisms of fluoroquinolone resistance in 156 Escherichia coli strains clinically isolated from urinary tract infections.
    Yasufuku T; Shigemura K; Shirakawa T; Nakano Y; Tanaka K; Arakawa S; Kinoshita S; Nishimura K; Kawabata M; Fujisawa M
    Scand J Infect Dis; 2011 Feb; 43(2):83-8. PubMed ID: 20942776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations of gyrA gene and parC gene in fluoroquinolone-resistant Escherichia coli isolates from sporadic diarrheal cases].
    Ishiguro F; Toho M; Yamazaki M; Matsuyuki S; Moriya K; Tanaka D; Isobe J; Kyota Y; Muraoka M
    Kansenshogaku Zasshi; 2006 Sep; 80(5):507-12. PubMed ID: 17073264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs.
    Kotb DN; Mahdy WK; Mahmoud MS; Khairy RMM
    BMC Infect Dis; 2019 Nov; 19(1):979. PubMed ID: 31752702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of fluoroquinolone resistance in Escherichia coli strains from ruminants.
    Jurado S; Orden JA; Horcajo P; De La Fuente R; Ruiz-Santa-Quiteria JA; Martínez-Pulgarín S; Domínguez-Bernal G
    J Vet Diagn Invest; 2008 May; 20(3):342-5. PubMed ID: 18460623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S; Yasuda M; Ito S; Takahashi Y; Ishihara S; Deguchi T; Maeda S; Kubota Y; Tamaki M; Fukushi H
    J Infect Chemother; 2004 Oct; 10(5):262-7. PubMed ID: 16163459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M; Fukuda H; Yokoi S; Ishihara S; Kawada Y; Deguchi T
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.